Page last updated: 2024-12-05
2-chloroacrylic acid
Description
2-Chloroacrylic acid is an organic compound with the formula CH2ClCHCOOH. It is a colorless liquid with a pungent odor. It is used in the synthesis of other chemicals, such as polymers and pharmaceuticals. 2-Chloroacrylic acid is a reactive compound and can be harmful to human health. It is also an environmental pollutant and is a concern due to its potential to accumulate in the food chain. 2-Chloroacrylic acid is studied for its use in various reactions and processes, including polymerization, where it acts as a monomer for polyvinyl chloride (PVC) production. It is also a key intermediate in the synthesis of various other organic chemicals and pharmaceuticals. Researchers investigate its properties, reactivity, and potential applications in various fields. '
```
2-chloroacrylic acid : A chlorocarboxylic acid that is acrylic acid in which the hydrogen at position 2 is substituted by chlorine. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]
Cross-References
| ID Source | ID |
|---|
| PubMed CID | 11735 |
| CHEBI ID | 73963 |
| SCHEMBL ID | 66157 |
| MeSH ID | M0487865 |
Synonyms (32)
| Synonym |
|---|
| einecs 209-953-9 |
| brn 1098503 |
| nsc 97174 |
| acrylic acid, 2-chloro- |
| chloroacrylic acid |
| .alpha.-chloroacrylic acid |
| nsc-97174 |
| 598-79-8 |
| 2-propenoic acid, 2-chloro- |
| nsc97174 |
| 2-chloroacrylic acid |
| 2-chloroprop-2-enoic acid |
| 2-chloro-2-propenoic acid |
| LMFA01090069 |
| AKOS006227807 |
| CHEBI:73963 |
| alpha-chloroacrylic acid |
| unii-n6b9ywm4xu |
| n6b9ywm4xu , |
| FT-0611901 |
| C20609 |
| SCHEMBL66157 |
| DTXSID5060514 |
| mfcd00014336 |
| Z1201617183 |
| Q27144284 |
| BCP13841 |
| 2-chloroacrylicacid |
| STR09625 |
| D93171 |
| EN300-147844 |
| CS-0187884 |
Roles (1)
| Role | Description |
|---|
| metabolite | Any intermediate or product resulting from metabolism. The term 'metabolite' subsumes the classes commonly known as primary and secondary metabolites. |
| [role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] |
Drug Classes (2)
| Class | Description |
|---|
| chlorocarboxylic acid | A carboxylic acid containing at least one chloro group. |
| alpha,beta-unsaturated monocarboxylic acid | A monocarboxylic acid in which the carbon of the carboxy group is directly attached to a C=C or C#C bond. |
| [compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res] |
Research
Studies (5)
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 3 (60.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 12.35
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| Metric | This Compound (vs All) |
|---|
| Research Demand Index | 12.35 (24.57) | | Research Supply Index | 1.95 (2.92) | | Research Growth Index | 4.30 (4.65) | | Search Engine Demand Index | 0.00 (26.88) | | Search Engine Supply Index | 0.00 (0.95) |
| |
Study Types
| Publication Type | This drug (%) | All Drugs (%) |
|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 6 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |